DK375988D0 - Salpetersyreesterderivat - Google Patents

Salpetersyreesterderivat

Info

Publication number
DK375988D0
DK375988D0 DK375988A DK375988A DK375988D0 DK 375988 D0 DK375988 D0 DK 375988D0 DK 375988 A DK375988 A DK 375988A DK 375988 A DK375988 A DK 375988A DK 375988 D0 DK375988 D0 DK 375988D0
Authority
DK
Denmark
Prior art keywords
alkyl
alkylene
suitable substituent
nitric acid
acid residual
Prior art date
Application number
DK375988A
Other languages
English (en)
Other versions
DK375988A (da
Inventor
Youichi Shiokawa
Koichi Takimoto
Kohei Takenaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of DK375988D0 publication Critical patent/DK375988D0/da
Publication of DK375988A publication Critical patent/DK375988A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK375988A 1987-07-20 1988-07-06 Salpetersyreesterderivat DK375988A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878717068A GB8717068D0 (en) 1987-07-20 1987-07-20 Nitric ester derivative

Publications (2)

Publication Number Publication Date
DK375988D0 true DK375988D0 (da) 1988-07-06
DK375988A DK375988A (da) 1989-01-21

Family

ID=10620954

Family Applications (1)

Application Number Title Priority Date Filing Date
DK375988A DK375988A (da) 1987-07-20 1988-07-06 Salpetersyreesterderivat

Country Status (19)

Country Link
US (2) US4923886A (da)
EP (1) EP0300400B1 (da)
JP (1) JPH0228167A (da)
KR (1) KR890002067A (da)
CN (1) CN1021046C (da)
AT (1) ATE102928T1 (da)
AU (1) AU623858B2 (da)
DE (1) DE3888415T2 (da)
DK (1) DK375988A (da)
FI (1) FI883402A (da)
GB (1) GB8717068D0 (da)
HU (1) HU203227B (da)
IL (1) IL86959A (da)
MX (1) MX12317A (da)
NO (1) NO172049C (da)
PH (1) PH24481A (da)
PT (1) PT88019B (da)
SU (2) SU1706388A3 (da)
ZA (1) ZA884987B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3941438A1 (de) * 1989-12-15 1991-06-20 Hoechst Ag Neue 2-substituierte 4-(3-alkyl-5-tert.-butyl-4-hydroxy-phenyl)-thiazole, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
IT1243367B (it) * 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
AU647599B2 (en) * 1991-03-27 1994-03-24 Sankyo Company Limited New thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators
JP3454531B2 (ja) * 1991-11-07 2003-10-06 三共株式会社 ニトロキシアルキルアミド誘導体
IT1256450B (it) * 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
DE69522118T2 (de) * 1994-12-15 2002-04-25 Sankyo Co., Ltd. Thiazolidonon- oder oxazolidinonderivate zur behandlung von angina pectoris und zusammensetzungen die diese als wirkstoffe enthält
AU701977B2 (en) * 1995-03-02 1999-02-11 Sankyo Company Limited Optically active thiazolidinone derivative
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
IL120531A (en) 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them
TR200102969T2 (tr) * 1999-04-15 2002-08-21 Bristol-Myers Squibb Company Siklik protein tirozin kinaz önleyicileri.
US7273866B2 (en) * 2002-12-20 2007-09-25 Bristol-Myers Squibb Company 2-aryl thiazole derivatives as KCNQ modulators
US6933308B2 (en) * 2002-12-20 2005-08-23 Bristol-Myers Squibb Company Aminoalkyl thiazole derivatives as KCNQ modulators
US7968575B2 (en) * 2004-05-05 2011-06-28 Renopharm Ltd. Nitric oxide donors and uses thereof
EP1753734A1 (en) * 2004-05-05 2007-02-21 Renopharm Ltd. Nitric oxide donors and uses thereof
US8134010B2 (en) * 2004-05-05 2012-03-13 Renopharm Ltd. Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
DE102009037555A1 (de) * 2009-08-13 2011-03-03 Synovo Gmbh Ein neuartiges, schonendes Verfahren zur direkten Nitrierung von Hydroxyl-, Thiol- und Aminogruppen in organischen Molekülen mittels in situ generiertem Kohlensäuredinitrat
KR101045041B1 (ko) * 2009-10-27 2011-06-28 (주)에스엠이엔지 봉합침 제조방법
ES2542702T3 (es) * 2011-10-24 2015-08-10 Nicox Science Ireland Compuestos donantes de óxido nítrico a base de quinona
SG11201501014YA (en) * 2012-08-23 2015-03-30 Cardiolynx Ag Extended release compositions of an aminoalkyl nitrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3433383A1 (de) * 1984-09-12 1986-03-20 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phenyl-acetonitril-derivate

Also Published As

Publication number Publication date
EP0300400B1 (en) 1994-03-16
CN1021046C (zh) 1993-06-02
AU1919988A (en) 1989-01-27
KR890002067A (ko) 1989-04-07
NO883208L (no) 1989-01-23
MX12317A (es) 1993-09-01
ZA884987B (en) 1989-05-30
NO172049B (no) 1993-02-22
IL86959A (en) 1992-12-01
US5010093A (en) 1991-04-23
SU1760984A3 (ru) 1992-09-07
NO883208D0 (no) 1988-07-19
HUT47551A (en) 1989-03-28
AU623858B2 (en) 1992-05-28
DK375988A (da) 1989-01-21
PH24481A (en) 1990-07-18
PT88019A (pt) 1989-06-30
CN1031226A (zh) 1989-02-22
ATE102928T1 (de) 1994-04-15
SU1706388A3 (ru) 1992-01-15
DE3888415T2 (de) 1994-07-14
FI883402A (fi) 1989-01-21
PT88019B (pt) 1995-03-01
FI883402A0 (fi) 1988-07-18
JPH0331709B2 (da) 1991-05-08
NO172049C (no) 1993-06-02
JPH0228167A (ja) 1990-01-30
IL86959A0 (en) 1988-12-30
HU203227B (en) 1991-06-28
EP0300400A1 (en) 1989-01-25
DE3888415D1 (de) 1994-04-21
US4923886A (en) 1990-05-08
GB8717068D0 (en) 1987-08-26

Similar Documents

Publication Publication Date Title
DK375988A (da) Salpetersyreesterderivat
ATE79880T1 (de) Chinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
PT95854A (pt) Processo para a preparacao de composicoes contendo derivados de pirimidona e analogos, uteis no tratamento da asma e de certas perturbacoes da pele
EP0263506A3 (en) Anticonvulsant composition containing amino acid derivative and use of said amino acid derivative
ATE101126T1 (de) Amide von cyclomethylen-1,2 bicarbonsaeure mit therapeutischer wirkung, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische zusammensetzungen.
DE3164314D1 (en) Azolylalkyl derivatives, process for their preparation and their use as fungicides
ES8705362A1 (es) Un procedimiento para la preparacion de nuevas aminas terciarias
EP0301466A3 (en) Uricosuric composition
SE8206230D0 (sv) Novel cyclic imines, their preparation and pharmaceutical compositions containing the same
JPS56110683A (en) Preparation of optical active epoxysuccinate
ES2061579T3 (es) Compuestos cefem y procedimientos para su preparacion.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment